Cannabis (Marijuana) Research Report
References

This is Archived Content. This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). Find current research and publications at nida.nih.gov.

  1. Timberlake DS. A comparison of drug use and dependence between blunt smokers and other cannabis users. Subst Use Misuse. 2009;44(3):401-415. doi:10.1080/10826080802347651
  2. Mehmedic Z, Chandra S, Slade D, et al. Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. J Forensic Sci. 2010;55(5):1209-1217. doi:10.1111/j.1556-4029.2010.01441.x
  3. Substance Abuse Center for Behavioral Health Statistics and Quality. Results from the 2018 National Survey on Drug Use and Health: Detailed Tables, SAMHSA. https://www.samhsa.gov/data/report/2018-nsduh-detailed-tables. Accessed December 2019.
  4. Carliner H, Mauro PM, Brown QL, et al. The widening gender gap in marijuana use prevalence in the U.S. during a period of economic change, 2002-2014. Drug Alcohol Depend. 2016;170:51-58. doi:10.1016/j.drugalcdep.2016.10.042
  5. Johnston L, O’Malley P, Miech R, Bachman J, Schulenberg J. Monitoring the Future National Survey Results on Drug Use: 1975-2018: Overview: Key Findings on Adolescent Drug Use. Ann Arbor, MI: Institute for Social Research, The University of Michigan; 2018.
  6. Center for Behavioral Health Statistics and Quality (CBHSQ). Drug Abuse Warning Network: 2011: Selected Tables of National Estimates of Drug-Related Emergency Department Visits. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013.
  7. Lenné MG, Dietze PM, Triggs TJ, Walmsley S, Murphy B, Redman JR. The effects of cannabis and alcohol on simulated arterial driving: Influences of driving experience and task demand. Accid Anal Prev. 2010;42(3):859-866. doi:10.1016/j.aap.2009.04.021
  8. Hartman RL, Huestis MA. Cannabis effects on driving skills. Clin Chem. 2013;59(3):478-492. doi:10.1373/clinchem.2012.194381
  9. Hartman RL, Brown TL, Milavetz G, et al. Cannabis effects on driving lateral control with and without alcohol. Drug Alcohol Depend. 2015;154:25-37. doi:10.1016/j.drugalcdep.2015.06.015
  10. Brady JE, Li G. Trends in Alcohol and Other Drugs Detected in Fatally Injured Drivers in the United States, 1999–2010. Am J Epidemiol. January 2014:kwt327. doi:10.1093/aje/kwt327
  11. Biecheler M-B, Peytavin J-F, Sam Group, Facy F, Martineau H. SAM survey on “drugs and fatal accidents”: search of substances consumed and comparison between drivers involved under the influence of alcohol or cannabis. Traffic Inj Prev. 2008;9(1):11-21. doi:10.1080/15389580701737561
  12. DRUID Final Report: Work Performed, Main Results and Recommendations. EU DRUID Programme; 2012. http://www.roadsafetyobservatory.com/Evidence/Details/10940.
  13. Elvik R. Risk of road accident associated with the use of drugs: a systematic review and meta-analysis of evidence from epidemiological studies. Accid Anal Prev. 2013;60:254-267. doi:10.1016/j.aap.2012.06.017
  14. Ramaekers JG, Berghaus G, van Laar M, Drummer OH. Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend. 2004;73(2):109-119.
  15. Li M-C, Brady JE, DiMaggio CJ, Lusardi AR, Tzong KY, Li G. Marijuana Use and Motor Vehicle Crashes. Epidemiol Rev. 2012;34(1):65-72. doi:10.1093/epirev/mxr017
  16. Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ. 2012;344:e536. doi:10.1136/bmj.e536
  17. Compton RP, Berning A. Drug and Alcohol Crash Risk. Washington, DC: National Highway Traffic Safety Administration; 2015. DOT HA 812 117.
  18. Hasin DS, Saha TD, Kerridge BT, et al. Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013. JAMA Psychiatry. 2015;72(12):1235-1242. doi:10.1001/jamapsychiatry.2015.1858
  19. Winters KC, Lee C-YS. Likelihood of developing an alcohol and cannabis use disorder during youth: Association with recent use and age. Drug Alcohol Depend. 2008;92(1-3):239-247. doi:10.1016/j.drugalcdep.2007.08.005
  20. Budney AJ, Hughes JR. The cannabis withdrawal syndrome. Curr Opin Psychiatry. 2006;19(3):233-238. doi:10.1097/01.yco.0000218592.00689.e5
  21. Gorelick DA, Levin KH, Copersino ML, et al. Diagnostic Criteria for Cannabis Withdrawal Syndrome. Drug Alcohol Depend. 2012;123(1-3):141-147. doi:10.1016/j.drugalcdep.2011.11.007
  22. Rotter A, Bayerlein K, Hansbauer M, et al. CB1 and CB2 receptor expression and promoter methylation in patients with cannabis dependence. Eur Addict Res. 2013;19(1):13-20. doi:10.1159/000338642
  23. Morgan CJA, Page E, Schaefer C, et al. Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms. Br J Psychiatry J Ment Sci. 2013;202(5):381-382. doi:10.1192/bjp.bp.112.121178
  24. Anthony JC, Warner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey. Exp Clin Psychopharmacol. 1994;2(3):244-268. doi:10.1037/1064-1297.2.3.244
  25. Lopez-Quintero C, Pérez de los Cobos J, Hasin DS, et al. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 2011;115(1-2):120-130. doi:10.1016/j.drugalcdep.2010.11.004
  26. Anthony JC. The epidemiology of cannabis dependence. In: Roffman RA, Stephens RS, eds. Cannabis Dependence: Its Nature, Consequences and Treatment. Cambridge, UK: Cambridge University Press; 2006:58-105.
  27. Hall WD, Pacula RL. Cannabis Use and Dependence: Public Health and Public Policy. Cambridge, UK: Cambridge University Press; 2003.
  28. Center for Behavioral Health Statistics and Quality (CBHSQ). Treatment Episode Data Set (TEDS): 2003-2013. National Admissions to Substance Abuse Treatment Services. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2015. BHSIS Series S-75, HHS Publication No. (SMA) 15-4934.
  29. Office of National Drug Control Policy, National Drug Control Strategy Data Supplement 2020, Feb. 2020, p. 95, Table #77 https://trumpwhitehouse.archives.gov/wp-content/uploads/2020/02/2020-NDCS-Data-Supplement.pdf
  30. Freeman TP, Morgan CJA, Hindocha C, Schafer G, Das RK, Curran HV. Just say “know”: how do cannabinoid concentrations influence users’ estimates of cannabis potency and the amount they roll in joints? Addict Abingdon Engl. 2014;109(10):1686-1694. doi:10.1111/add.12634
  31. Van der Pol P, Liebregts N, Brunt T, et al. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study. Addict Abingdon Engl. 2014;109(7):1101-1109. doi:10.1111/add.12508
  32. Campolongo P, Trezza V, Cassano T, et al. Perinatal exposure to delta-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neurotransmission in rats. Addict Biol. 2007;12(3-4):485-495. doi:10.1111/j.1369-1600.2007.00074.x
  33. Antonelli T, Tomasini MC, Tattoli M, et al. Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring. Cereb Cortex N Y N 1991. 2005;15(12):2013-2020. doi:10.1093/cercor/bhi076
  34. Verrico CD, Gu H, Peterson ML, Sampson AR, Lewis DA. Repeated Δ9-tetrahydrocannabinol exposure in adolescent monkeys: persistent effects selective for spatial working memory. Am J Psychiatry. 2014;171(4):416-425. doi:10.1176/appi.ajp.2013.13030335
  35. Rubino T, Realini N, Braida D, et al. Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. Hippocampus. 2009;19(8):763-772. doi:10.1002/hipo.20554
  36. Gleason KA, Birnbaum SG, Shukla A, Ghose S. Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia. Transl Psychiatry. 2012;2:e199. doi:10.1038/tp.2012.122
  37. Quinn HR, Matsumoto I, Callaghan PD, et al. Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2008;33(5):1113-1126. doi:10.1038/sj.npp.1301475
  38. Batalla A, Bhattacharyya S, Yücel M, et al. Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PloS One. 2013;8(2):e55821. doi:10.1371/journal.pone.0055821
  39. Filbey FM, Aslan S, Calhoun VD, et al. Long-term effects of marijuana use on the brain. Proc Natl Acad Sci U S A. 2014;111(47):16913-16918. doi:10.1073/pnas.1415297111
  40. Pagliaccio D, Barch DM, Bogdan R, et al. Shared predisposition in the association between cannabis use and subcortical brain structure. JAMA Psychiatry. 2015;72(10):994-1001. doi:10.1001/jamapsychiatry.2015.1054
  41. Volkow ND, Swanson JM, Evins AE, et al. Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA Psychiatry. 2016;73(3):292-297. doi:10.1001/jamapsychiatry.2015.3278
  42. Auer R, Vittinghoff E, Yaffe K, et al. Association between lifetime marijuana use and cognitive function in middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. JAMA Intern Med. February 2016. doi:10.1001/jamainternmed.2015.7841
  43. Meier MH, Caspi A, Ambler A, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A. 2012;109(40):E2657-E2664. doi:10.1073/pnas.1206820109
  44. Jackson NJ, Isen JD, Khoddam R, et al. Impact of adolescent marijuana use on intelligence: Results from two longitudinal twin studies. Proc Natl Acad Sci U S A. 2016;113(5):E500-E508. doi:10.1073/pnas.1516648113
  45. Secades-Villa R, Garcia-Rodríguez O, Jin CJ, Wang S, Blanco C. Probability and predictors of the cannabis gateway effect: a national study. Int J Drug Policy. 2015;26(2):135-142. doi:10.1016/j.drugpo.2014.07.011
  46. Weinberger AH, Platt J, Goodwin RD. Is cannabis use associated with an increased risk of onset and persistence of alcohol use disorders? A three-year prospective study among adults in the United States. Drug Alcohol Depend. February 2016. doi:10.1016/j.drugalcdep.2016.01.014
  47. Pistis M, Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biol Psychiatry. 2004;56(2):86-94. doi:10.1016/j.biopsych.2004.05.006
  48. Agrawal A, Neale MC, Prescott CA, Kendler KS. A twin study of early cannabis use and subsequent use and abuse/dependence of other illicit drugs. Psychol Med. 2004;34(7):1227-1237.
  49. Panlilio LV, Zanettini C, Barnes C, Solinas M, Goldberg SR. Prior exposure to THC increases the addictive effects of nicotine in rats. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2013;38(7):1198-1208. doi:10.1038/npp.2013.16
  50. Cadoni C, Pisanu A, Solinas M, Acquas E, Di Chiara G. Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology (Berl). 2001;158(3):259-266. doi:10.1007/s002130100875
  51. Levine A, Huang Y, Drisaldi B, et al. Molecular mechanism for a gateway drug: epigenetic changes initiated by nicotine prime gene expression by cocaine. Sci Transl Med. 2011;3(107):107ra109. doi:10.1126/scitranslmed.3003062
  52. Schweinsburg AD, Brown SA, Tapert SF. The influence of marijuana use on neurocognitive functioning in adolescents. Curr Drug Abuse Rev. 2008;1(1):99-111.
  53. Macleod J, Oakes R, Copello A, et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet Lond Engl. 2004;363(9421):1579-1588. doi:10.1016/S0140-6736(04)16200-4
  54. Silins E, Horwood LJ, Patton GC, et al. Young adult sequelae of adolescent cannabis use: an integrative analysis. Lancet Psychiatry. 2014;1(4):286-293. doi:10.1016/S2215-0366(14)70307-4
  55. Fergusson DM, Boden JM. Cannabis use and later life outcomes. Addict Abingdon Engl. 2008;103(6):969-976; discussion 977-978. doi:10.1111/j.1360-0443.2008.02221.x
  56. Brook JS, Lee JY, Finch SJ, Seltzer N, Brook DW. Adult work commitment, financial stability, and social environment as related to trajectories of marijuana use beginning in adolescence. Subst Abuse. 2013;34(3):298-305. doi:10.1080/08897077.2013.775092
  57. McCaffrey DF, Pacula RL, Han B, Ellickson P. Marijuana Use and High School Dropout: The Influence of Unobservables. Health Econ. 2010;19(11):1281-1299. doi:10.1002/hec.1561
  58. Gruber AJ, Pope HG, Hudson JI, Yurgelun-Todd D. Attributes of long-term heavy cannabis users: a case-control study. Psychol Med. 2003;33(8):1415-1422.
  59. Macdonald S, Hall W, Roman P, Stockwell T, Coghlan M, Nesvaag S. Testing for cannabis in the work-place: a review of the evidence. Addict Abingdon Engl. 2010;105(3):408-416. doi:10.1111/j.1360-0443.2009.02808.x
  60. Zwerling C, Ryan J, Orav EJ. The efficacy of preemployment drug screening for marijuana and cocaine in predicting employment outcome. JAMA. 1990;264(20):2639-2643.
  61. Radhakrishnan R, Wilkinson ST, D’Souza DC. Gone to Pot - A Review of the Association between Cannabis and Psychosis. Front Psychiatry. 2014;5:54. doi:10.3389/fpsyt.2014.00054
  62. Blanco C, Hasin DS, Wall MM, et al. Cannabis Use and Risk of Psychiatric Disorders: Prospective Evidence From a US National Longitudinal Study. JAMA Psychiatry. February 2016. doi:10.1001/jamapsychiatry.2015.3229
  63. Di Forti M, Iyegbe C, Sallis H, et al. Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. Biol Psychiatry. 2012;72(10):811-816. doi:10.1016/j.biopsych.2012.06.020
  64. Caspi A, Moffitt TE, Cannon M, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry. 2005;57(10):1117-1127. doi:10.1016/j.biopsych.2005.01.026
  65. Delforterie MJ, Lynskey MT, Huizink AC, et al. The relationship between cannabis involvement and suicidal thoughts and behaviors. Drug Alcohol Depend. 2015;150:98-104. doi:10.1016/j.drugalcdep.2015.02.019
  66. Borges G, Bagge CL, Orozco R. A literature review and meta-analyses of cannabis use and suicidality. J Affect Disord. 2016;195:63-74. doi:10.1016/j.jad.2016.02.007
  67. Tashkin DP. Effects of marijuana smoking on the lung. Ann Am Thorac Soc. 2013;10(3):239-247. doi:10.1513/AnnalsATS.201212-127FR
  68. Owen KP, Sutter ME, Albertson TE. Marijuana: respiratory tract effects. Clin Rev Allergy Immunol. 2014;46(1):65-81. doi:10.1007/s12016-013-8374-y
  69. Polen MR, Sidney S, Tekawa IS, Sadler M, Friedman GD. Health care use by frequent marijuana smokers who do not smoke tobacco. West J Med. 1993;158(6):596-601.
  70. Hashibe M, Morgenstern H, Cui Y, et al. Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2006;15(10):1829-1834. doi:10.1158/1055-9965.EPI-06-0330
  71. Hancox RJ, Poulton R, Ely M, et al. Effects of cannabis on lung function: a population-based cohort study. Eur Respir J. 2010;35(1):42-47. doi:10.1183/09031936.00065009
  72. Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering Myocardial Infarction by Marijuana. Circulation. 2001;103(23):2805-2809. doi:10.1161/01.CIR.103.23.2805
  73. Thomas G, Kloner RA, Rezkalla S. Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. Am J Cardiol. 2014;113(1):187-190. doi:10.1016/j.amjcard.2013.09.042
  74. Jones RT. Cardiovascular system effects of marijuana. J Clin Pharmacol. 2002;42(11 Suppl):58S - 63S.
  75. Lacson JCA, Carroll JD, Tuazon E, Castelao EJ, Bernstein L, Cortessis VK. Population-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk. Cancer. 2012;118(21):5374-5383. doi:10.1002/cncr.27554
  76. Daling JR, Doody DR, Sun X, et al. Association of marijuana use and the incidence of testicular germ cell tumors. Cancer. 2009;115(6):1215-1223. doi:10.1002/cncr.24159
  77. Galli JA, Sawaya RA, Friedenberg FK. Cannabinoid Hyperemesis Syndrome. Curr Drug Abuse Rev. 2011;4(4):241-249.
  78. Bachhuber MA, Saloner B, Cunningham CO, Barry CL. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Intern Med. 2014;174(10):1668-1673. doi:10.1001/jamainternmed.2014.4005
  79. Chelsea L. Shover, Corey S. Davis, Sanford C. Gordon, and Keith Humphreys, Association between medical cannabis laws and opioid overdose mortality has reversed over time, PNAS June 25, 2019 116 (26) 12624-12626.
  80. Röhrich J, Schimmel I, Zörntlein S, et al. Concentrations of delta9-tetrahydrocannabinol and 11-nor-9-carboxytetrahydrocannabinol in blood and urine after passive exposure to Cannabis smoke in a coffee shop. J Anal Toxicol. 2010;34(4):196-203.
  81. Cone EJ, Bigelow GE, Herrmann ES, et al. Non-smoker exposure to secondhand cannabis smoke. I. Urine screening and confirmation results. J Anal Toxicol. 2015;39(1):1-12. doi:10.1093/jat/bku116
  82. Wang X, Derakhshandeh R, Liu J, et al. One Minute of Marijuana Secondhand Smoke Exposure Substantially Impairs Vascular Endothelial Function. J Am Heart Assoc. 2016;5(8). doi:10.1161/JAHA.116.003858
  83. Martin CE, Longinaker N, Mark K, Chisolm MS, Terplan M. Recent trends in treatment admissions for marijuana use during pregnancy. J Addict Med. 2015;9(2):99-104. doi:10.1097/ADM.0000000000000095
  84. Young-Wolff KC, Tucker L-Y, Alexeeff S, et al. Trends in Self-reported and Biochemically Tested Marijuana Use Among Pregnant Females in California From 2009-2016. JAMA. 2017;318(24):2490. doi:10.1001/jama.2017.17225
  85. Kline J, Hutzler M, Levin B, Stein Z, Susser M, Warburton D. Marijuana and spontaneous abortion of known karyotype. Paediatr Perinat Epidemiol. 1991;5(3):320-332.
  86. Wilcox AJ, Weinberg CR, Baird DD. Risk factors for early pregnancy loss. Epidemiol Camb Mass. 1990;1(5):382-385.
  87. Asch RH, Smith CG. Effects of delta 9-THC, the principal psychoactive component of marijuana, during pregnancy in the rhesus monkey. J Reprod Med. 1986;31(12):1071-1081.
  88. Campolongo P, Trezza V, Ratano P, Palmery M, Cuomo V. Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents. Psychopharmacology (Berl). 2011;214(1):5-15. doi:10.1007/s00213-010-1892-x
  89. Fried PA, Watkinson B, Gray R. A follow-up study of attentional behavior in 6-year-old children exposed prenatally to marihuana, cigarettes, and alcohol. Neurotoxicol Teratol. 1992;14(5):299-311.
  90. Goldschmidt L, Day NL, Richardson GA. Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol. 2000;22(3):325-336.
  91. Fried PA, Smith AM. A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function. Neurotoxicol Teratol. 2001;23(1):1-11.
  92. Janisse JJ, Bailey BA, Ager J, Sokol RJ. Alcohol, tobacco, cocaine, and marijuana use: relative contributions to preterm delivery and fetal growth restriction. Subst Abuse. 2014;35(1):60-67. doi:10.1080/08897077.2013.804483
  93. Hayatbakhsh MR, Flenady VJ, Gibbons KS, et al. Birth outcomes associated with cannabis use before and during pregnancy. Pediatr Res. 2012;71(2):215-219. doi:10.1038/pr.2011.25
  94. Shiono PH, Klebanoff MA, Nugent RP, et al. The impact of cocaine and marijuana use on low birth weight and preterm birth: a multicenter study. Am J Obstet Gynecol. 1995;172(1 Pt 1):19-27.
  95. Mark K, Desai A, Terplan M. Marijuana use and pregnancy: prevalence, associated characteristics, and birth outcomes. Arch Womens Ment Health. 2016;19(1):105-111. doi:10.1007/s00737-015-0529-9
  96. Schempf AH, Strobino DM. Illicit Drug Use and Adverse Birth Outcomes: Is It Drugs or Context? J Urban Health Bull N Y Acad Med. 2008;85(6):858-873. doi:10.1007/s11524-008-9315-6
  97. Tobacco, drug use in pregnancy can double risk of stillbirth. https://www.nichd.nih.gov/news/releases/Pages/121113-stillbirth-drug-use.aspx. Accessed December 16, 2016.
  98. Marijuana Use During Pregnancy and Lactation - ACOG. ACOG. http://www.acog.org/Resources-And-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Marijuana-Use-During-Pregnancy-and-Lactation. Published July 2015. Accessed October 12, 2016.
  99. Roberson EK, Patrick WK, Hurwitz EL. Marijuana use and maternal experiences of severe nausea during pregnancy in Hawai’i. Hawaii J Med Public Health J Asia Pac Med Public Health. 2014;73(9):283-287.
  100. Westfall RE, Janssen PA, Lucas P, Capler R. Survey of medicinal cannabis use among childbearing women: patterns of its use in pregnancy and retroactive self-assessment of its efficacy against “morning sickness.” Complement Ther Clin Pract. 2006;12(1):27-33. doi:10.1016/j.ctcp.2005.09.006
  101. Trezza V, Campolongo P, Cassano T, et al. Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats. Psychopharmacology (Berl). 2008;198(4):529-537. doi:10.1007/s00213-008-1162-3
  102. Mereu G, Fà M, Ferraro L, et al. Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. Proc Natl Acad Sci U S A. 2003;100(8):4915-4920. doi:10.1073/pnas.0537849100
  103. Fried PA, Makin JE. Neonatal behavioural correlates of prenatal exposure to marihuana, cigarettes and alcohol in a low risk population. Neurotoxicol Teratol. 1987;9(1):1-7.
  104. De Moraes Barros MC, Guinsburg R, Mitsuhiro S, Chalem E, Laranjeira RR. Neurobehavioral profile of healthy full-term newborn infants of adolescent mothers. Early Hum Dev. 2008;84(5):281-287. doi:10.1016/j.earlhumdev.2007.07.001
  105. Richardson GA, Ryan C, Willford J, Day NL, Goldschmidt L. Prenatal alcohol and marijuana exposure: effects on neuropsychological outcomes at 10 years. Neurotoxicol Teratol. 2002;24(3):309-320.
  106. Goldschmidt L, Day NL, Richardson GA. Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol. 2000;22(3):325-336.
  107. Sonon KE, Richardson GA, Cornelius JR, Kim KH, Day NL. Prenatal marijuana exposure predicts marijuana use in young adulthood. Neurotoxicol Teratol. 2015;47:10-15. doi:10.1016/j.ntt.2014.11.003
  108. Perez-Reyes M, Wall ME. Presence of delta9-tetrahydrocannabinol in human milk. N Engl J Med. 1982;307(13):819-820. doi:10.1056/NEJM198209233071311
  109. Astley SJ, Little RE. Maternal marijuana use during lactation and infant development at one year. Neurotoxicol Teratol. 1990;12(2):161-168.
  110. Djulus J, Moretti M, Koren G. Marijuana use and breastfeeding. Can Fam Physician Médecin Fam Can. 2005;51:349-350.
  111. Budney AJ, Roffman R, Stephens RS, Walker D. Marijuana Dependence and Its Treatment. Addict Sci Clin Pract. 2007;4(1):4-16.
  112. Diamond G, Panichelli-Mindel SM, Shera D, Dennis M, Tims F, Ungemack J. Psychiatric Syndromes in Adolescents with Marijuana Abuse and Dependency in Outpatient Treatment. J Child Adolesc Subst Abuse. 2006;15(4):37-54. doi:10.1300/J029v15n04_02
  113. Di Forti M, Quattrone D, Freeman TP, et al. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. The Lancet 2019;6(5);427-436 doi. 10.1016/S2215-0366(19)30048-3
  114. Pearlson GD, Stevens MC, D'Souza DC. Cannabis and driving. Front Psychiatry. 2021;12:689444. Published 2021 Sep 24. doi:10.3389/fpsyt.2021.689444
  115. National Academies of Sciences, Engineering, and Medicine. 2017. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press. DOI: 10.17226/24625.
  116. Chow RM, Marascalchi B, Abrams WB, Peiris NA, Odonkor CA, Cohen SP. Driving under the influence of cannabis: A framework for future policy. Anesth Analg. 2019;128(6):1300-1308. doi:10.1213/ANE.0000000000003575
  117. Compton, R. (2017, July). Marijuana-Impaired Driving - A Report to Congress. (DOT HS 812 440). Washington, DC: National Highway Traffic Safety Administration.
  118. Sevigny EL. Cannabis and driving ability. Curr Opin Psychol. 2021;38:75-79. doi:10.1016/j.copsyc.2021.03.003
  119. Brooks-Russell A, Brown T, Friedman K, et al. Simulated driving performance among daily and occasional cannabis users. Accid Anal Prev. 2021;160:106326. doi:10.1016/j.aap.2021.106326
  120. Simmons SM, Caird JK, Sterzer F, Asbridge M. The effects of cannabis and alcohol on driving performance and driver behaviour: a systematic review and meta-analysis. Addiction. 2022;117(7):1843-1856. doi:10.1111/add.15770
  121. Rup J, Freeman TP, Perlman C, Hammond D. Cannabis and mental health: Prevalence of use and modes of cannabis administration by mental health status. Addict Behav. 2021;121:106991. doi:10.1016/j.addbeh.2021.106991
  122. Ortiz-Medina MB, Perea M, Torales J, et al. Cannabis consumption and psychosis or schizophrenia development. Int J Soc Psychiatry. 2018;64(7):690-704. doi:10.1177/0020764018801690
  123. Wadsworth E, Craft S, Calder R, Hammond D. Prevalence and use of cannabis products and routes of administration among youth and young adults in Canada and the United States: A systematic review.Addict Behav. 2022;129:107258. doi:10.1016/j.addbeh.2022.107258
  124. Large M, Sharma S, Compton MT, Slade T, Nielssen O. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry. 2011;68(6):555-561. doi:10.1001/archgenpsychiatry.2011.5
  125. Starzer MSK, Nordentoft M, Hjorthøj C. Rates and predictors of conversion to schizophrenia or bipolar disorder following substance-induced psychosis [published correction appears in Am J Psychiatry. 2019 Apr 1;176(4):324]. Am J Psychiatry. 2018;175(4):343-350. doi:10.1176/appi.ajp.2017.17020223
  126. Kendler KS, Ohlsson H, Sundquist J, Sundquist K. Prediction of onset of substance-induced psychotic disorder and its progression to schizophrenia in a Swedish national sample. Am J Psychiatry. 2019;176(9):711-719. doi:10.1176/appi.ajp.2019.18101217
  127. Murrie B, Lappin J, Large M, Sara G. Transition of substance-induced, brief, and atypical psychoses to schizophrenia: A systematic review and meta-analysis. Schizophr Bull. 2020;46(3):505-516. doi:10.1093/schbul/sbz102
  128. Pasman JA, Verweij KJH, Gerring Z, et al. GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia [published correction appears in Nat Neurosci. 2019 Jul;22(7):1196]. Nat Neurosci. 2018;21(9):1161-1170. doi:10.1038/s41593-018-0206-1
  129. Johnson EC, Demontis D, Thorgeirsson TE, et al. A large-scale genome-wide association study meta-analysis of cannabis use disorder [published correction appears in Lancet Psychiatry. 2022 Apr;9(4):e12]. Lancet Psychiatry. 2020;7(12):1032-1045. doi:10.1016/S2215-0366(20)30339-4
  130. Gillespie NA, Kendler KS. Use of genetically informed methods to clarify the nature of the association between cannabis use and risk for schizophrenia. JAMA Psychiatry. 2021;78(5):467-468. doi:10.1001/jamapsychiatry.2020.3564
  131. Ganesh S, D'Souza DC. Cannabis and psychosis: Recent epidemiological findings continuing the "causality debate". Am J Psychiatry. 2022;179(1):8-10. doi:10.1176/appi.ajp.2021.21111126
  132. Gobbi G, Atkin T, Zytynski T, et al. Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: A systematic review and meta-analysis [published correction appears in JAMA Psychiatry. 2019 Apr 1;76(4):447]. JAMA Psychiatry. 2019;76(4):426-434. doi:10.1001/jamapsychiatry.2018.4500
  133. Feingold D, Weinstein A. Cannabis and depression. Adv Exp Med Biol. 2021;1264:67-80. doi:10.1007/978-3-030-57369-0_5
  134. Delforterie MJ, Lynskey MT, Huizink AC, et al. The relationship between cannabis involvement and suicidal thoughts and behaviors. Drug Alcohol Depend. 2015;150:98-104. doi:10.1016/j.drugalcdep.2015.02.019
  135. Han B, Compton WM, Einstein EB, Volkow ND. Associations of suicidality trends with cannabis use as a function of sex and depression status. JAMA Netw Open. 2021;4(6):e2113025. Published 2021 Jun 1. doi:10.1001/jamanetworkopen.2021.13025
  136. Kimbrel NA, Meyer EC, DeBeer BB, Gulliver SB, Morissette SB. The impact of cannabis use disorder on suicidal and nonsuicidal self-injury in Iraq/Afghanistan-era veterans with and without mental health disorders. Suicide Life Threat Behav. 2018;48(2):140-148. doi:10.1111/sltb.12345
  137. Allan NP, Ashrafioun L, Kolnogorova K, Raines AM, Hoge CW, Stecker T. Interactive effects of PTSD and substance use on suicidal ideation and behavior in military personnel: Increased risk from marijuana use. Depress Anxiety. 2019;36(11):1072-1079. doi:10.1002/da.22954
  138. Chester LA, Valmaggia LR, Kempton MJ, et al. Influence of cannabis use on incidence of psychosis in people at clinical high risk. Psychiatry Clin Neurosci. 2023;10.1111/pcn.13555. doi:10.1111/pcn.13555